TRIB

Trinity Biotech PLC

Price

$11.13

return (12m)

-47.35%

p/e

-0.18

p/bv

-0.17

DIVIDEND YIELD

0.00%

TRIB price

Trinity Biotech

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment TRIB

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-1.51%

3 months

-38.35%

1 year

-47.35%

2 years

-86.37%

5 years

-96.83%

10 years

-99.43%

Fundamentals TRIB

Valuation

P/E

-0.18

Sector -2.51

Industry 1.15

P/BV

-0.17

Sector 2.18

Industry 2.39

P/Revenue (PSR)

0.12

Sector 1.96

Industry 0.76

EV/EBITDA

-1.62

Sector -24.92

Industry -7.95

EV/EBIT

-1.48

Sector -39.41

Industry -21.02

P/EBITDA

-0.32

Sector 0.30

Industry 1.06

P/EBIT

-0.29

Sector -2.09

Industry 3.13

P/Total Assets

0.12

Sector 1.17

Industry 0.94

P/Net Current Assets

-0.09

Sector -10.97

Industry -20.47

P/Working Capital

-0.12

Sector -4.59

Industry -51.71

EPS

-69.15

Sector -0.91

Industry -0.57

BVPS

-71.98

Sector 3.80

Industry 5.19

Efficiency

Gross Margin

36.40%

Sector 44.01%

Industry 30.93%

EBITDA Margin

-56.97%

Sector -352.48%

Industry -76.74%

EBIT Margin

-62.45%

Sector -207.71%

Industry -12.19%

Operating Margin

-23.85%

Sector -25.20%

Industry -7.54%

Net Profit Margins

-65.64%

Sector -29.28%

Industry -16.90%

Asset Turnover

0.24

Sector 0.12

Industry 0.22

Profitability

ROE

96.07%

Sector -36.13%

Industry -28.68%

ROA

-65.75%

Sector -29.39%

Industry -15.38%

ROIC

-5.82%

Sector -439.03%

Industry -111.96%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

0.25

Sector 1.87

Industry 1.10

Net Debt / EBITDA

-0.77

Sector -1.58

Industry -28.84

Net Debt / EBIT

-0.71

Sector -0.83

Industry 3.17

Net Debt / Equity

-0.16

Sector -0.36

Industry 0.13

Gross Debt / Equity

-0.23

Sector 0.16

Industry 0.51

Equity/Assets

-0.68

Sector 0.42

Industry 0.26

Liabilities/Assets

1.68

Sector 0.46

Industry 0.48

Growth

5Y Revenue CAGR

5.36%

Sector -

Industry -

5Y Earnings CAGR

0.00%

Sector -

Industry -

Fundamentals TRIB

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
TRIB	-0.18	-0.17	96.07%	0.00%	$12.25 M	-65.64%
ISRG	39.74	6.82	17.15%	0.00%	$124.72 B	28.45%
ABT	33.60	3.57	10.61%	2.33%	$182.28 B	11.65%
MDT	22.67	2.17	9.59%	3.35%	$108.83 B	13.20%
BSX	16.43	0.00	-%	0.00%	$67.50 B	19.57%
TMDX	14.97	5.21	34.80%	0.00%	$2.57 B	27.04%
IDXX	40.43	28.46	70.38%	0.00%	$44.28 B	24.63%
RMD	19.99	4.68	23.41%	1.15%	$30.37 B	27.44%
SYK	37.03	5.38	14.52%	1.08%	$123.56 B	13.21%
PHG	19.28	1.89	9.80%	3.88%	$24.98 B	6.30%
COHR	104.97	4.47	4.26%	0.00%	$49.22 B	7.10%
INMD	10.92	1.44	13.18%	0.00%	$952.25 M	23.27%
DXCM	31.70	12.09	38.14%	0.00%	$31.69 B	20.12%
EW	49.23	0.00	-%	0.00%	$49.47 B	15.43%
IMRA	64.74	1.13	1.74%	92.47%	$101.64 M	0.00%
BDX	40.36	1.90	4.72%	2.29%	$45.94 B	5.33%
BDXB	8.75	0.54	6.12%	0.00%	$13.76 B	8.36%
ALGN	28.99	2.83	9.77%	0.00%	$11.99 B	9.99%
ABMD	64.27	11.14	17.32%	0.00%	$17.15 B	24.84%
SNN	12.97	2.54	19.61%	2.46%	$13.45 B	8.66%
ZBH	23.79	1.43	6.00%	1.03%	$18.11 B	9.05%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

TRIB Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	06/05/2015	07/01/2015	33.00000000
Dividends	06/06/2014	07/01/2014	33.00000000
Dividends	06/06/2013	07/01/2013	30.00000000
Dividends	06/06/2012	06/22/2012	22.50000000
Dividends	06/07/2011	06/23/2011	60.00000000

ABOUT Trinity Biotech

Trinity Biotech PLC

Average Investor10 user rating

4.0 (0 people)

United States

34 years

Founded: 1992

1992

Time since IPO - 34 years

543

Employees

Trinity Biotech PLC (United States) is listed on the Nasdaq and has a market capitalization of $12.25 million, with shareholders equity totaling $-71.98 million.

The company employs approximately 543 people and operates in the Health sector, within the Medical Supplies and Equipment industry.

Over the past 12 months, Trinity Biotech PLC reported $105.34 million in revenue, generating net income of $-69.15 million.

Key financial metrics include a P/E ratio of -0.18, a price-to-book (P/B) ratio of -0.17, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker TRIB.

Market cap

$12.25 million

Net worth

$-71.98 million

$-71,980,000.00

Assets

$105.17 million

$105,170,000.00

Total Shares Outstanding

1.00 million

1,000,000

Average Daily Trading Volume

$1.61 million

$1,607,180.10

Sector

Health

Industry

Medical Supplies and Equipment

TRIB

TRIB revenue and profits

Financial Results TRIB

DRAG THE FRAME TO SEE MORE DATA

TRIB cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$105.37 76,89% (12M)

P/E

45.51

2.54%

ROE

3.78%

P/BV

1.72

CI - Cigna

$282.06 8,72% (12M)

P/E

10.87

2.18%

ROE

16.04%

P/BV

1.74

CNC - Centene

$63.76 143,27% (12M)

P/E

-5.98

0.00%

ROE

-22.51%

P/BV

1.35

HUM - Humana

$374.50 53,59% (12M)

P/E

34.70

0.96%

ROE

6.63%

P/BV

2.30

SNY - Sanofi

$42.95 --7,09% (12M)

P/E

6.98

4.12%

ROE

18.43%

P/BV

1.29

HCA - HCA Healthcare

$406.61 12,69% (12M)

P/E

12.92

0.75%

ROE

-213.15%

P/BV

-27.54

LLY - Eli Lilly

$1,121.36 47,65% (12M)

P/E

40.46

0.57%

ROE

81.02%

P/BV

32.78

NVS - Novartis

$153.67 32,95% (12M)

P/E

23.36

1.98%

ROE

30.41%

P/BV

7.11